People with sickle cell disease experience excruciating pain crises, tissue and organ damage, and shortened life expectancy. The lab of Stuart Orkin made crucial discoveries that, in the hands of CRISPR Therapeutics and Vertex Pharmaceuticals, became an FDA-approved gene therapy that is making a monumental impact on patients with sickle cell disease.
Related Posts
Acting NIAID Chief Steps Down Amid Rising Ebola, Hantavirus Concerns
May 26, 2026
Dr. Jeffery Taubenberger has stepped down as acting head of NIAID amid reported leadership changes, raising concerns about infectious disease preparedness.
Atopic Dermatitis Linked to Higher Retinal Detachment Risk
May 26, 2026
New research reveals adults with atopic dermatitis face increased five-year rates of retinal detachment and surgical complications, highlighting unexpected eye...
Declining Physical Activity May Signal Cognitive Decline in Seniors
May 25, 2026
A gradual drop in physical activity among older adults may signal more than normal aging, sometimes reflecting early cognitive changes, mood issues, or health problems that deserve timely attention.
Common Air Pollutants Affect Brain and Lungs Within Hours
May 25, 2026
New UK study reveals diesel exhaust, woodsmoke, cooking emissions, and cleaning products can alter brain activity and lung function in just four hours.